Liquid biopsy enables non-invasive cancer detection, monitoring, and molecular profiling through simple blood draws.
Detect cancer signals in blood before tumors are visible on imaging.
Profile circulating tumor DNA for real-time mutation tracking.
Track therapy response and detect resistance emergence non-invasively.
Monitor for cancer recurrence after surgery with high sensitivity.
Single blood test screens for signals from multiple cancer types.
Capture the full molecular diversity of cancer that single biopsies miss.
Patient Analog connects cutting-edge research with biotech intelligence infrastructure.
Explore Patient AnalogThis premium domain is available for acquisition. Submit your inquiry or make an offer below.